Clene Inc.

CLNN

Healthcare|Biotechnology|US

$3.95

-0.02 (-0.50%)

Cash / Share

$0.76

Next Earnings Report

Mar 11, 2027

EPS est. -$0.51 · Revenue est. $67.5K

Financing Filings (last 12 months)

Shelf registrations / offering prospectuses — latest Sep 16, 2026 (424B5). Possible dilution.

Upcoming Data Readouts (0)

No upcoming completion dates found in active trials.

Awaiting Results (1)

Trials past primary completion date but still active — data readout may be imminent.

Jun 2026

An Open-Label Extension for the Phase 2 Study in Early Symptomatic Amyotrophic Lateral Sclerosis Patients on Stable Background Therapy to Assess Bioenergetic Catalysis With CNM-Au8 to Slow Disease Progression in ALS

NCT05299658

Recent Press Releases

Clene Reports Third Quarter 2026 Financial Results and Recent Operating Highlights

Nov 4, 2026 · GlobeNewsWire

Clene Announces New Drug Application Submission to FDA for CNM-Au8 for the Treatment of ALS

Oct 19, 2026 · GlobeNewsWire

Clene to Present at Upcoming Investor Conferences

Sep 22, 2026 · GlobeNewsWire

Clene Announces Closing of $4 Million Registered Direct Offering Extending Capital Runway Beyond FDA Decision on CNM-Au8® NDA

Sep 21, 2026 · GlobeNewsWire

Clene Announces $4 Million Registered Direct Offering

Sep 15, 2026 · GlobeNewsWire

Clene to Present at Upcoming September Investor Conferences

Sep 3, 2026 · GlobeNewsWire

Clene to Present at the Emerging Growth Conference

Aug 17, 2026 · GlobeNewsWire

Clene Reports Second Quarter 2026 Financial Results and Recent Operating Highlights

Aug 14, 2026 · GlobeNewsWire

SEC Filings (96)

Last two years from EDGAR. Insider Form 4s are on the Ownership tab.

Filed	Form	What it is	Links
Nov 4, 2026	10-Q	Quarterly report	Document Index
Nov 4, 2026	8-K	Material event	Document Index
Oct 20, 2026	8-K	Material event	Document Index
Oct 19, 2026	8-K	Material event	Document Index
Oct 13, 2026	SC 13G/A	Passive 5%+ stake	Document Index
Sep 16, 2026	8-K	Material event	Document Index
Sep 16, 2026	424B5	Offering prospectus	Document Index
Aug 14, 2026	SC 13G/A	Passive 5%+ stake	Document Index
Aug 14, 2026	8-K	Material event	Document Index
Aug 14, 2026	10-Q	Quarterly report	Document Index
Aug 11, 2026	SC 13G/A	Passive 5%+ stake	Document Index
Aug 10, 2026	8-K	Material event	Document Index
Aug 4, 2026	SC 13G	Passive 5%+ stake	Document Index
Jun 5, 2026	S-8	Employee stock plan	Document Index
May 22, 2026	SD		Document Index
May 22, 2026	8-K	Material event	Document Index
May 15, 2026	SC 13G/A	Passive 5%+ stake	Document Index
May 14, 2026	SC 13G/A	Passive 5%+ stake	Document Index
May 14, 2026	SC 13G/A	Passive 5%+ stake	Document Index
May 14, 2026	8-K	Material event	Document Index
May 14, 2026	10-Q	Quarterly report	Document Index
May 12, 2026	SC 13G/A	Passive 5%+ stake	Document Index
May 5, 2026	8-K	Material event	Document Index
May 5, 2026	424B5	Offering prospectus	Document Index
May 5, 2026	424B5	Offering prospectus	Document Index
May 4, 2026	8-K	Material event	Document Index
Apr 10, 2026	ARS	Annual report to holders	Document Index
Apr 10, 2026	DEFA14A	Proxy / shareholder vote	Document Index
Apr 10, 2026	DEF 14A	Proxy / shareholder vote	Document Index
Mar 17, 2026	10-K	Annual report	Document Index
Mar 17, 2026	8-K	Material event	Document Index
Mar 12, 2026	8-K	Material event	Document Index
Feb 24, 2026	8-K	Material event	Document Index
Jan 13, 2026	8-K	Material event	Document Index
Jan 12, 2026	8-K	Material event	Document Index
Jan 9, 2026	424B5	Offering prospectus	Document Index
Dec 30, 2025	25-NSE		Document Index
Dec 3, 2025	8-K	Material event	Document Index
Dec 3, 2025	8-K	Material event	Document Index
Nov 13, 2025	SC 13G/A	Passive 5%+ stake	Document Index